What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Alzheimer's disease
- Gene
Her primary scientific interests are in Alzheimer's disease, Internal medicine, Endocrinology, Neuroscience and Pathology.
Her biological study spans a wide range of topics, including Degenerative disease, Dementia and Amyloid.
Her studies deal with areas such as Positron emission tomography, Predictive value of tests and Frontotemporal dementia as well as Amyloid.
Agneta Nordberg works mostly in the field of Internal medicine, limiting it down to topics relating to Human brain and, in certain cases, Caudate nucleus, as a part of the same area of interest.
Her study in Endocrinology is interdisciplinary in nature, drawing from both Receptor, Nicotinic agonist and Acetylcholine receptor.
Her Disease research is multidisciplinary, incorporating perspectives in Pathological, Psychiatry, Neurology, Intensive care medicine and Biomarker.
Her most cited work include:
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. (3499 citations)
- Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. (3499 citations)
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (1884 citations)
What are the main themes of her work throughout her whole career to date?
Agneta Nordberg mainly investigates Internal medicine, Endocrinology, Alzheimer's disease, Disease and Nicotinic agonist.
Her work carried out in the field of Internal medicine brings together such families of science as Acetylcholinesterase and Oncology.
Pathology covers Agneta Nordberg research in Alzheimer's disease.
Her studies deal with areas such as Positron emission tomography and In vivo as well as Pathology.
Her study in the field of Dementia also crosses realms of Context.
Her Nicotinic agonist study combines topics in areas such as Nicotine, Pharmacology and Acetylcholine receptor.
She most often published in these fields:
- Internal medicine (52.54%)
- Endocrinology (37.57%)
- Alzheimer's disease (28.61%)
What were the highlights of her more recent work (between 2017-2021)?
- Disease (26.60%)
- Positron emission tomography (24.20%)
- Internal medicine (52.54%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Disease, Positron emission tomography, Internal medicine, Dementia and Biomarker.
She has researched Disease in several fields, including Carbohydrate metabolism, Neuroimaging and Astrocyte.
Her biological study spans a wide range of topics, including Cognition and Oncology.
Her Dementia research is multidisciplinary, relying on both Differential diagnosis, Cognitive impairment and Intensive care medicine.
Her Biomarker study incorporates themes from Alzheimer's disease, Florbetaben, Neurodegeneration and Phospho tau.
Her research on Alzheimer's disease often connects related topics like Hippocampus.
Between 2017 and 2021, her most popular works were:
- Tau PET imaging in neurodegenerative tauopathies-still a challenge. (193 citations)
- Tau PET imaging in neurodegenerative tauopathies-still a challenge. (193 citations)
- Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. (93 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Alzheimer's disease
Her main research concerns Dementia, Disease, Neurodegeneration, Positron emission tomography and Neurology.
Her Dementia research is under the purview of Internal medicine.
In the subject of general Internal medicine, her work in Amyloid pet is often linked to Population study, thereby combining diverse domains of study.
Her Disease research includes elements of Biomarker, Incidence and Astrocyte.
The concepts of her Positron emission tomography study are interwoven with issues in Fibril, Biophysics, Molecular model, Binding site and Amyloid.
Her Neurology study integrates concerns from other disciplines, such as Progressive supranuclear palsy and Cerebrospinal fluid, Pathophysiology, Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
